Better support for rheumatic heart disease medication
Part of Heart & circulation, Infections clinical trials.
This trial tests whether added support helps people stick to their prescribed antibiotics for rheumatic heart disease. It includes adults, children, guardians, community health workers, and healthcare workers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with rheumatic heart disease
- You are prescribed a regular antibiotic to prevent infections (secondary prophylaxis)
- You are 18 or older, or a child 12-17, or a guardian of a child 5-17 with RHD
- You can understand and agree to take part in the study
- You do not have a medical reason that makes the antibiotic unsafe for you
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing whether a vaccine can prevent rheumatic heart disease in children. It involves children aged 5 to 8 years who are healthy, live in certain areas, and have no history of heart problems. The study will check children's hearts with an ultrasound and follow them over time.
This study tests whether a program in schools can help prevent rheumatic heart disease in children. If your child is between 5 and 16 years old and attends a participating school, they may be able to join.
This trial tests a program to help people who have had a heart attack, stroke, or other blood vessel disease take their heart medications every day. It is for patients who sometimes miss their pills and want better support.
This study tests whether an antibiotic called azithromycin can help prevent complications and disease progression in young people with rheumatic heart disease (RHD—a type of heart valve damage). You would take this medication monthly and visit the clinic for check-ups to see if it helps protect your heart.
This study tests a remote health support program for adults with heart failure who may have palliative care needs. It aims to see if the program can help manage symptoms and reduce hospital visits. Caregivers and healthcare professionals are also involved.
This study tests a new strategy to help people in Uganda who were found to have rheumatic heart disease (a condition affecting the heart valve) stay connected to their care. Researchers want to understand what works best to keep patients from being lost to follow-up and ensure they get the treatment they need.
Hear when a new Rheumatic Heart Disease in Children trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.